Transfer of genetic information from injured cells may explain stem cell functional and phenotypic changes without the need for transdifferentiation into tissue cells. On the …
TM Rager, JK Olson, Y Zhou, Y Wang… - Journal of pediatric …, 2016 - Elsevier
Purpose Treatment options for necrotizing enterocolitis (NEC) remain inadequate. Bone marrow-derived mesenchymal stem cells (BM-MSCs) can protect the intestines from NEC …
H Qian, H Yang, W Xu, Y Yan… - International …, 2008 - spandidos-publications.com
In the present study, we investigated the therapeutic potential of mesenchymal stem cells (MSCs) in a rat acute renal failure (ARF) model and explored the possible in vivo and in vitro …
JM Quimby, TL Webb, DS Gibbons… - Journal of feline …, 2011 - journals.sagepub.com
The feasibility of autologous intrarenal mesenchymal stem cell (MSC) therapy in cats with chronic kidney disease (CKD) was investigated. Six cats (two healthy, four with CKD) …
Background aims Mesenchymal stromal cells (MSCs) are characterized by paracrine and immunomodulatory functions capable of changing the microenvironment of damaged brain …
Twenty-five to 40% of diabetic patients develop diabetic nephropathy, a clinical syndrome that comprises renal failure and increased risk of cardiovascular disease. It represents the …
H Asanuma, BA Vanderbrink, MT Campbell… - Journal of Surgical …, 2011 - Elsevier
BACKGROUND: Mesenchymal stem cells (MSCs) hold promise for the treatment of renal disease. While MSCs have been shown to accelerate recovery and prevent acute renal …
H Cao, H Qian, W Xu, W Zhu, X Zhang, Y Chen… - Biotechnology …, 2010 - Springer
Mesenchymal stem cells (MSCs) are candidates for cell therapy of kidney diseases. However, the application of MSC derived from human umbilical cord (UC-MSC) in treating …